HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of ET-1 in hypoxia-induced mitosis of cultured rat carotid body chemoreceptors.

Abstract
The mammalian carotid body (CB) contains O2-chemoreceptors, i.e. glomus cells, which display increased mitoses and endothelin-1 (ET-1) expression during chronic hypoxia. To investigate whether endogenous ET-1 might mediate these mitogenic effects, we quantified bromodeoxyuridine (BrdU) uptake by tyrosine hydroxylase (TH)-positive glomus cells in rat CB cultures using double-label immunofluorescence. In normoxia (20% O2), 2-day exposure to ET-1 (10-1000 nM) caused a dose-dependent increase in BrdU uptake which peaked (approximately 55% of TH+ cells) at around 500 nM ET-1. In chronic hypoxia (5% O2) alone, BrdU uptake was stimulated (approximately 46% of TH+ cells) relative to normoxia (approximately 30%), but the effect was abolished in the presence of specific (BQ 123) or non-specific (PD 142893) ETA receptor antagonists (10(-5) M). Thus paracrine/autocrine release of ET-1 in the hypoxic carotid body may promote glomus cell mitosis via ET(A) receptors.
AuthorsM Paciga, C Vollmer, C Nurse
JournalNeuroreport (Neuroreport) Vol. 10 Issue 18 Pg. 3739-44 (Dec 16 1999) ISSN: 0959-4965 [Print] England
PMID10716201 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelin-1
  • Receptor, Endothelin A
  • Receptors, Endothelin
  • Bromodeoxyuridine
Topics
  • Animals
  • Bromodeoxyuridine (metabolism)
  • Carotid Body (drug effects, pathology)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Chemoreceptor Cells (drug effects, pathology)
  • Chronic Disease
  • Endothelin-1 (pharmacology, physiology)
  • Hypoxia (metabolism, physiopathology)
  • Mitosis
  • Rats
  • Receptor, Endothelin A
  • Receptors, Endothelin (physiology)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: